Gwendolyn McMillin

Gwendolyn A. McMillin received a BA from Grinnell College, in Grinnell, IA, and a PhD in pharmacology and toxicology from the University of Utah, in Salt Lake City, UT. She completed post-doctoral training in Clinical Chemistry through the University of Utah, and is certified by the American Board of Clinical Chemistry (ABCC) in the areas of Clinical Chemistry and Toxicological Chemistry. She is currently an Associate Professor (clinical) of Pathology at the University of Utah, and is a Medical Director at ARUP Laboratories, responsible for the areas of Clinical Toxicology and Pharmacogenomics.

Dr McMillin is actively involved in professional associations. For example, she served as Chair of the TDM/Toxicology Division of the American Association for Clinical Chemistry (AACC), Chair of the Toxicological Chemistry exam and Continuing Education Committee for the American Board of Clinical Chemistry (ABCC), a Member of the Toxicology Resource Committee for the College of American Pathologists (CAP), and is co-Chair of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology’s (IATDMCT) 2013 Congress. She was also involved in forming the Personalized Medicine Division of the AACC. Dr McMillin serves as an Editorial Board member for professional journals such as Therapeutic Drug Monitoring and the Journal of Analytical Toxicology, and has published nearly 100 original research manuscripts, review articles, and book chapters. Her research is focused on evaluating and assuring clinical utility of drug testing and pharmacogenomics, funded by several commercial contracts and federal grants.

 

  • 2003-Present:  Medical Director, Toxicology and Pharmacogenomics, ARUP Laboratories, Inc., Salt Lake City, UT, USA
  • 2014-Present:  Professor (Clinical), University of Utah, School of Medicine, Department of Pathology, Salt Lake City, UT, USA
  • 2010-2014:  Associate Professor (Clinical), University of Utah, School of Medicine, Department of Pathology, Salt Lake City, UT, USA
  • 2004-2010:  Assistant Professor (Clinical), University of Utah, School of Medicine, Department of Pathology, Salt Lake City, UT, USA
  • 1996-2001:  Medical Director, Toxicology and Pharmacogenomics, ARUP Laboratories, Inc., Salt Lake City, UT, USA
  • 1994-1996: Senior Scientist, University of Utah, Department of Pharmacology and Toxicology, Anticonvulsant Drug Development Program, Salt Lake City, UT, USA
  • 2005: Diplomate certification through American Board of Clinical Chemistry in Toxicological Chemistry
  • 2004: Diplomate certification through American Board of Clinical Chemistry in Clinical Chemistry
  • 1994: Ph.D. awarded in Pharmacology through the University of Utah, College of Pharmacy, Salt Lake City, UT, USA
  • 1989: B.A. awarded in Psychology through Grinnell College, Grinnell, IA, USA

Activities in IATDMCT:

  • Current Treasurer; Co-chair of the 2013 annual meeting (SLC, UT);
  • Contributing member of the Clinical Toxicology/Drugs of Abuse Committee;
  • Invited speaker (DUPHAT 2014, IATDMCT 2015)

Activities in AACC (American Association for Clinical Chemistry):

  • Current vice-chair of the 2016 annual meeting (Philadelphia, PA);
  • Current officer in the Personalized Medicine Division;
  • Former chair of the TDM/Toxicology Division (2009-2014);
  • Symposium coordinator for annual meeting (2010);
  • Chair nominating committee (2009-2010);
  • Invited speaker at several annual and regional meetings

Activities in CAP (College of American Pathologists):

  • Current member of the Toxicology Resource Committee and Pharmacology Working Group;
  • Invited speaker at several annual meetings

Activities in ABCC (American Board of Clinical Chemistry):

  • Board member, chair of Toxicology exam committee (2007-2012)

Editorial Board Member: Therapeutic Drug Monitoring; Journal of Analytical Toxicology

Active publication record:
I have authored/published in excess of 70 original manuscripts; 10 review articles; 25 book chapters; and 150 abstracts

My experience as IATDMCT Treasurer since 2013 has prepared me to serve on the Council.  I am organized and successful in completing projects in a timely manner, and I am both excited and privileged to have opportunity to continue serving the organization by managing the finances for another term.